Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares)
-
Shares outstanding
-
239,647,920
-
Total 13F shares
-
39,044,821
-
Share change
-
-644,186
-
Total reported value
-
$4,860,728,814
-
Put/Call ratio
-
194%
-
Price per share
-
$124.57
-
Number of holders
-
268
-
Value change
-
-$139,456,827
-
Number of buys
-
113
-
Number of sells
-
145
Institutional Holders of BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) as of Q1 2023
As of 31 Mar 2023,
BioNTech SE - Ordinary Shares, no par value per share (EUR1.00 nominal amount) (including Ordinary Shares represented by American Depositary Shares) (BNTX) was held by
268 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
39,044,821 shares.
The largest 10 holders included
BAILLIE GIFFORD & CO, PRIMECAP MANAGEMENT CO/CA/, Temasek Holdings (Private) Ltd, FLOSSBACH VON STORCH AG, Artisan Partners Limited Partnership, BlackRock Inc., Capital World Investors, MORGAN STANLEY, DEUTSCHE BANK AG\, and ALTRINSIC GLOBAL ADVISORS LLC.
This page lists
270
institutional shareholders reporting positions in this security
for the Q1 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.